CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 110 enrolled
Drug / intervention
Enhanced E-cigarette Coaching +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03575468
NCT03575468N/ACompleted

Enhanced E-cigarette Coaching Intervention for Dual Users of Cigarettes and E-cigarettes

Consumer Wellness Solutions·interventional·Posted Jul 2, 2018·Updated Oct 16, 2023

In Brief

A clinical study evaluating Enhanced E-cigarette Coaching and Quitline treatment as usual for Smoking Cessation. Completed, enrolled 110 participants across 1 site.

Detailed Summary

The purpose of this study is to develop and pilot test an enhanced behavioral coaching intervention for dual users of cigarettes and electronic nicotine delivery systems (ENDS) who call tobacco quitlines for help quitting smoking.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 2, 2018
Enrollment StartMay 7, 2018
Primary CompletionAug 31, 2020
Study CompletionOct 1, 2020
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 8 years ago

Interventions

Enhanced E-cigarette Coachingbehavioral

The EEC intervention calls will include assessment of e-cigarette use and discussion about how and why e-cigarettes are being used on every call. In addition to the standard quitline cessation program, the enhanced program will include education (via quit coaches and two tailored quit guides), behavioral support tailored to dual users, and shared decision making strategies to address how and why FDA-approved quitting aids and ENDS are being used and to develop an integrated quit plan based on callers' decisions.

Quitline treatment as usualbehavioral

The standard tobacco quitline program is a proactive 5-call intervention grounded in social cognitive theory and the U.S. Public Health Service clinical practices guidelines for treating tobacco use and dependence. All enrollees in the study are eligible for 2-8 weeks of nicotine replacement therapy (depending on their standard quitline benefit offering), if they medically qualify and/or return a medical override letter from their doctor.